by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Safrel Pharmaceuticals LLC Warning Letter Details

Warning Letter

Safrel Pharmaceuticals LLC

178 Ridge Road Dayton , NJ 08810-2532 United States

Issue DateAugust 07, 2026

FEI Number3042030663

Violations3

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

Safrel Pharmaceuticals LLC FDA Warning Letter, August 7, 2026